• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Japan approves Medtronic’s Micra leadless pacemaker

Japan approves Medtronic’s Micra leadless pacemaker

February 17, 2017 By Brad Perriello

Medtronic's Micra TPSMedtronic (NYSE:MDT) said today that Japanese regulators approved its Micra leadless pacemaker, which it claims as the world’s smallest pacemaker.

At 1/10th the size of a conventional pacemaker, or roughly the size of a large vitamin, Micra is designed to be implanted via catheter in the right ventricle to deliver single-chamber pacing. The device has an estimated 12-year battery life and is approved for full-body MRI scans. The FDA approved Micra in April 2016.

Medtronic said the approval from Japan’s Pharmaceuticals & Medical Device Agency was based on its single-arm, 744-patient Micra TPS study at 56 centers in 19 countries including Japan.

“Medtronic is excited to be the first to offer a miniaturized, leadless pacemaker to patients in Japan,” cardiac rhythm & heart failure president Dr. John Liddicoat said in prepared remarks. “We look forward to working with Japan’s Ministry of Health, Labor & Welfare to gain reimbursement for Micra so patients can gain access to this innovative technology as quickly as possible.”

“The development of a leadless pacemaker which can be implanted with a less invasive procedure has been eagerly awaited by physicians and patients in Japan,” added Dr. Kyoko Soejima of Kyorin University. “The safety and efficacy of the Micra TPS has been confirmed in my hospital as well as in other hospitals across the world that took part in the Micra TPS global clinical trial.”

Although it’s designed to be retrievable, Micra can be left in the body and permanently deactivated so a new device can be implanted if needed. Twelve-month data released at the annual meeting of the European Society of Cardiology in Rome last year showed a 96% freedom-from-complication rate and a 48% lower risk of major complications.

Last month the U.S. Centers for Medicare & Medicaid Services released a National Coverage Determination for leadless cardiac pacemakers, meaning Medicare and Medicaid patients will have access to coverage for Micra implantations.

Filed Under: Cardiovascular, Regulatory/Compliance, Wall Street Beat Tagged With: Cardiac Rhythm Management, Medtronic

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy